Pancreatic Cancer Research

ResearcherNanjing Drum Tower HospitalActive in the last 2 years

Hao Cheng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6621-7614; OpenAlex author ID A5101925055. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
38
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 3 papers · 2023: none · 2024: 1 paper · 2025: 5 papers

Papers 11

  1. SP1-Mediated Glycolytic Reprogramming Promotes Tumorigenesis and Progression in Pancreatic Cancer. Last author DOI 10.1002/advs.202510071↗
  2. Clinical characteristics of pancreatic cancer presenting with acute pancreatitis: a propensity-matched cohort study. Co-author DOI 10.1007/s00464-025-11654-z↗
  3. CD44 identified as a diagnostic biomarker for highly malignant CA19-9 negative pancreatic cancer. Co-author DOI 10.1016/j.canlet.2025.217713↗
  4. Survival and pathological response in pancreatic ductal adenocarcinoma after preoperative therapy with PD-1 blockade plus chemoradiotherapy followed by surgica… Last author DOI 10.1080/07853890.2025.2541314↗
  5. DHCR7 Promotes Liver Metastasis of Pancreatic Cancer Through PI3K-Akt Signaling Pathway. Last author DOI 10.1111/cas.70185↗
  6. Prognostic value of peripheral blood fibrinogen-to-albumin ratio and neutrophil-to-lymphocyte ratio in patients with locally advanced or metastatic pancreatic … Co-author DOI 10.62347/zohp7650↗
  7. Pancreatic cancer-associated diabetes mellitus is characterized by reduced β-cell secretory capacity, rather than insulin resistance. Co-author DOI 10.1016/j.diabres.2022.109223↗
  8. Folate receptor-positive circulating tumor cells predict survival and recurrence patterns in patients undergoing resection for pancreatic cancer. Co-author DOI 10.3389/fonc.2022.1012609↗
  9. Case Report: Pathologic Complete Response to Induction Therapy in a Patient With Potentially Resectable Pancreatic Cancer. Co-author DOI 10.3389/fonc.2022.898119↗
  10. Ligand-targeted polymerase chain reaction for the detection of folate receptor-positive circulating tumour cells as a potential diagnostic biomarker for pancre… Co-author DOI 10.1111/cpr.12880↗
  11. HtrA1 suppresses the growth of pancreatic cancer cells by modulating Notch-1 expression. Co-author DOI 10.1590/1414-431x20187718↗

Closest collaborators

The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yudong Qiu · 8 shared papers, 2020–2025 · strength 1.37
  2. Song Zhang · 2 shared papers, 2025 · strength 0.40
  3. Shanshan Shen · 2 shared papers, 2025 · strength 0.40
  4. Jiatong Tang · 2 shared papers, 2025 · strength 0.39
  5. Neng Tang · 2 shared papers, 2025 · strength 0.39
  6. Chao Yan · 2 shared papers, 2025 · strength 0.39
  7. Hexing Hang · 2 shared papers, 2025 · strength 0.39
  8. Linxi Zhu · 2 shared papers, 2022–2025 · strength 0.31
  9. Qi Li · 2 shared papers, 2022–2025 · strength 0.31
  10. Yu Xie · 1 shared paper, 2025 · strength 0.27
  11. Wei He · 2 shared papers, 2020–2022 · strength 0.26
  12. Huizi Sha · 1 shared paper, 2025 · strength 0.21
  13. Juan Du · 1 shared paper, 2025 · strength 0.21
  14. Jun Chen · 1 shared paper, 2025 · strength 0.21
  15. Elyar Abaydulla · 1 shared paper, 2025 · strength 0.21
  16. Yixuan Zhang · 1 shared paper, 2025 · strength 0.20
  17. Wei Wei · 1 shared paper, 2025 · strength 0.20
  18. Yudong Qiu · 1 shared paper, 2025 · strength 0.20
  19. Yiming Pan · 2 shared papers, 2018–2020 · strength 0.20
  20. Yuanyuan Yu · 1 shared paper, 2025 · strength 0.19
  21. Ying Lv · 1 shared paper, 2025 · strength 0.19
  22. Hongzhen Li · 1 shared paper, 2025 · strength 0.19
  23. Jiaqi Shi · 1 shared paper, 2025 · strength 0.19
  24. Shuang Nie · 1 shared paper, 2025 · strength 0.19
  25. Helmut Friess · 1 shared paper, 2025 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.